CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma
Jie Sun,1,2 Xiaoquan Zhu,3 Yanyang Zhao,3 Qi Zhou,3 Ruomei Qi,3 Hui Liu1,2 1Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 2Graduate School of Peking Unio...
Saved in:
Main Authors: | Sun J (Author), Zhu X (Author), Zhao Y (Author), Zhou Q (Author), Qi R (Author), Liu H (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma
by: Wang Z, et al.
Published: (2024) -
Identification of prognostic factors in patients with diffuse large B-cell lymphoma
by: Fang Peng, et al.
Published: (2017) -
Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma
by: Soyeon Choi, et al.
Published: (2022) -
A prognostic 15-gene model based on differentially expressed genes among metabolic subtypes in diffuse large B-cell lymphoma
by: Jun Hou, et al.
Published: (2023) -
Primary diffuse large B-cell lymphoma of the mandible
by: Juliana Mota Siqueira, et al.
Published: (2019)